Profarma Distribuidora de Produtos Farmaceuticos SA operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Profarma Distribuidora de Produtos Farmaceuticos SA with three other
drug stores in Latin America:
Empreendimentos Pague Menos SA
(2020
sales of 6.89 billion Brazilian Reals [US$1.29 billion]
),
Dimed SA Distribuidora do Medicamentos
(2.82 billion Brazilian Reals [US$527.82 million]
of which 91%
was Retail), and
Farmacias Benavides S.A.B. de C.V.
which is
based in MEXICO
(13.87 billion Mexican Pesos [US$695.52 million]
of which 77%
was Pharmacies).
Sales Analysis.
During the second
quarter of 2021, sales at Profarma Distribuidora de Produtos Farmaceuticos SA totalled
1.56 billion Brazilian Reals.
This is
an increase of 25.0%
from the 1.25 billion Brazilian Reals in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 3.06 billion Brazilian Reals, which is
15.4% higher
than through the first two quarters of 2020.
During the previous 12 quarters, sales at Profarma Distribuidora de Produtos Farmaceuticos SA have increased compared with the same quarter in the previous year.
Profarma Distribuidora de Produtos Farmaceuticos SA reported sales of 5.48 billion Brazilian Reals (US$1.03 billion)
for the
year ending
December of 2020.
This
represents
an
increase of 14.2%
versus 2019, when the company's sales were 4.80 billion Brazilian Reals.
Sales at Profarma Distribuidora de Produtos Farmaceuticos SA have increased during each of the previous five years
(and since 2015, sales have increased a total of 58%).
Sales of Pharmaceutical Distribution saw an increase
of
16.5% in 2020, from
4.50 billion Brazilian Reals to 5.24 billion Brazilian Reals.
Not all segments of Profarma Distribuidora de Produtos Farmaceuticos SA experienced an increase in sales in 2020:
sales of Pharmaceutical Retail fell 11.2% to 1.00 billion Brazilian Reals.